Urvi Mujumdar

1.4k total citations
23 papers, 908 citations indexed

About

Urvi Mujumdar is a scholar working on Oncology, Genetics and Cancer Research. According to data from OpenAlex, Urvi Mujumdar has authored 23 papers receiving a total of 908 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 6 papers in Genetics and 6 papers in Cancer Research. Recurrent topics in Urvi Mujumdar's work include Cutaneous Melanoma Detection and Management (8 papers), Skin Protection and Aging (5 papers) and Cancer Genomics and Diagnostics (5 papers). Urvi Mujumdar is often cited by papers focused on Cutaneous Melanoma Detection and Management (8 papers), Skin Protection and Aging (5 papers) and Cancer Genomics and Diagnostics (5 papers). Urvi Mujumdar collaborates with scholars based in United States, Australia and Canada. Urvi Mujumdar's co-authors include Amanda Hummer, Klaus J. Busam, Marianne Berwick, Colin B. Begg, Stephen B. Gruber, Bruce K. Armstrong, William G. Hawkins, Mary S. Brady, Daniel G. Coit and Robert C. Millikan and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Environmental Health Perspectives.

In The Last Decade

Urvi Mujumdar

22 papers receiving 891 citations

Peers

Urvi Mujumdar
Urvi Mujumdar
Citations per year, relative to Urvi Mujumdar Urvi Mujumdar (= 1×) peers Anna Måsbäck

Countries citing papers authored by Urvi Mujumdar

Since Specialization
Citations

This map shows the geographic impact of Urvi Mujumdar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Urvi Mujumdar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Urvi Mujumdar more than expected).

Fields of papers citing papers by Urvi Mujumdar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Urvi Mujumdar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Urvi Mujumdar. The network helps show where Urvi Mujumdar may publish in the future.

Co-authorship network of co-authors of Urvi Mujumdar

This figure shows the co-authorship network connecting the top 25 collaborators of Urvi Mujumdar. A scholar is included among the top collaborators of Urvi Mujumdar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Urvi Mujumdar. Urvi Mujumdar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xie, Yang, Urvi Mujumdar, Hongbo Yang, et al.. (2023). EE173 Economic Evaluation of Exagamglogene Autotemcel (EXA-CEL) Gene-Edited Therapy in Patients with Sickle Cell Disease with Recurrent Vaso-Occlusive Crises. Value in Health. 26(6). S91–S91. 3 indexed citations
2.
Mujumdar, Urvi, Karen Wells, Gregory L. Kucera, et al.. (2023). Use of Anti-Inflammatory Drugs and Lower Esophageal Sphincter-Relaxing Drugs and Risk of Esophageal and Gastric Cancers. UNC Libraries.
3.
Hopkins, Claire, Stella Lee, Wytske J. Fokkens, et al.. (2022). Dupilumab achieves durable reduction in severity of symptoms rated most important by patients with chronic rhinosinusitis with nasal polyps. Journal of Allergy and Clinical Immunology. 149(2). AB142–AB142. 1 indexed citations
4.
Rothenberg, Marc E., Evan S. Dellon, Albert J. Bredenoord, et al.. (2022). Dupilumab Improves Clinical and Histologic Aspects of Disease in Adult and Adolescent Patients With Eosinophilic Esophagitis at Week 24: Results from Part B of the 3-Part LIBERTY EoE TREET Study. Journal of Allergy and Clinical Immunology. 149(2). AB312–AB312. 7 indexed citations
5.
Kamat, Siddhesh, Degang Wang, Urvi Mujumdar, et al.. (2021). S415 Increasing Prevalence of Eosinophilic Esophagitis in the United States from 2015 to 2018. The American Journal of Gastroenterology. 116(1). S184–S185. 2 indexed citations
6.
Lal, Lincy S., et al.. (2016). Evaluation of Different Rules for Line of Therapy (LOT) Assignment in Non-Small Cell Lung Cancer (NSCLC) Patients. Value in Health. 19(3). A73–A73. 1 indexed citations
7.
Feinberg, Bruce A., et al.. (2015). Patient reported outcomes reveal discordance between Patient and Physician assessment of disease burden in patients with Rheumatoid Arthritis. Value in Health. 18(3). A262–A262. 1 indexed citations
8.
Engel, Lawrence S., Jaya M. Satagopan, Camelia S. Sima, et al.. (2013). Sun Exposure, Vitamin D Receptor Genetic Variants, and Risk of Breast Cancer in the Agricultural Health Study. Environmental Health Perspectives. 122(2). 165–171. 17 indexed citations
9.
Engel, Lawrence S., Irene Orlow, Camelia S. Sima, et al.. (2012). Vitamin D Receptor Gene Haplotypes and Polymorphisms and Risk of Breast Cancer: A Nested Case–Control Study. Cancer Epidemiology Biomarkers & Prevention. 21(10). 1856–1867. 36 indexed citations
10.
Mujumdar, Urvi, Jennifer L. Hay, Amanda Hummer, et al.. (2009). Sun protection and skin self‐examination in melanoma survivors. Psycho-Oncology. 18(10). 1106–1115. 73 indexed citations
11.
Orlow, Irene, Bradley S. Bloom, Irina Ostrovnaya, et al.. (2009). Evaluation of the Clonal Origin of Multiple Primary Melanomas Using Molecular Profiling. Journal of Investigative Dermatology. 129(8). 1972–1982. 23 indexed citations
12.
Orlow, Irene, Bernard J. Park, Urvi Mujumdar, et al.. (2008). DNA Damage and Repair Capacity in Patients With Lung Cancer: Prediction of Multiple Primary Tumors. Journal of Clinical Oncology. 26(21). 3560–3566. 46 indexed citations
13.
Kricker, Anne, Bruce K. Armstrong, Chris Goumas, et al.. (2007). Ambient UV, personal sun exposure and risk of multiple primary melanomas. Cancer Causes & Control. 18(3). 295–304. 88 indexed citations
14.
Fortuny, Joan, Christine Cole Johnson, Kari Bohlke, et al.. (2007). Use of Anti-Inflammatory Drugs and Lower Esophageal Sphincter–Relaxing Drugs and Risk of Esophageal and Gastric Cancers. Clinical Gastroenterology and Hepatology. 5(10). 1154–1159.e3. 40 indexed citations
15.
Begg, Colin B., Amanda Hummer, Urvi Mujumdar, et al.. (2006). A design for cancer case–control studies using only incident cases: experience with the GEM study of melanoma. International Journal of Epidemiology. 35(3). 756–764. 43 indexed citations
16.
Kanetsky, Peter A., Timothy R. Rebbeck, Amanda Hummer, et al.. (2006). Population-Based Study of Natural Variation in the Melanocortin-1 Receptor Gene and Melanoma. Cancer Research. 66(18). 9330–9337. 86 indexed citations
17.
Hay, Jennifer L., et al.. (2005). Skin Cancer Risk Discussions in Melanoma-Affected Families. Journal of Cancer Education. 20(4). 240–246. 24 indexed citations
18.
Busam, Klaus J., Urvi Mujumdar, Amanda Hummer, et al.. (2004). Cutaneous Desmoplastic Melanoma. The American Journal of Surgical Pathology. 28(11). 1518–1525. 141 indexed citations
19.
Begg, Colin B., Amanda Hummer, Urvi Mujumdar, et al.. (2004). Familial aggregation of melanoma risks in a large population-based sample of melanoma cases. Cancer Causes & Control. 15(9). 957–965. 28 indexed citations
20.
Gruber, Stephen B., Mark M. Entius, Gloria M. Petersen, et al.. (1998). Pathogenesis of adenocarcinoma in Peutz-Jeghers syndrome.. PubMed. 58(23). 5267–70. 136 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026